56.34
+4.48
+(8.64%)
At close: January 30 at 2:49:41 PM GMT-3
Research analysis
Earnings estimate
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| No. of analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low estimate | 0 | 0 | 0 | 0 |
| High estimate | 0 | 0 | 0 | 0 |
| Year ago EPS | -- | -- | -- | -- |
Revenue estimate
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| No. of analysts | 18 | 10 | 24 | 24 |
| Avg. Estimate | 96.9B | 92.96B | 371.65B | 386.44B |
| Low estimate | 94.15B | 91.05B | 367.97B | 370.54B |
| High estimate | 98.97B | 95.02B | 374.07B | 402.43B |
| Year ago sales | 93.81B | 88.44B | 357.78B | 371.65B |
| Sales growth (year/est) | 3.29% | 5.12% | 3.88% | 3.98% |
EPS trend
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| Current estimate | 0 | 0 | 0 | 0 |
| 7 days ago | 0 | 0 | 0 | 0 |
| 30 days ago | 0 | 0 | 0 | 0 |
| 60 days ago | 0 | 0 | 0 | 0 |
| 90 days ago | 0 | 0 | 0 | 0 |
EPS revisions
| Currency in USD | Current qtr. (Dec 2024) | Next qtr. (Mar 2025) | Current year (2024) | Next year (2025) |
|---|---|---|---|---|
| Up last 7 days | -- | -- | -- | -- |
| Up last 30 days | -- | -- | -- | -- |
| Down last 7 days | -- | -- | -- | -- |
| Down last 30 days | -- | -- | -- | -- |
Growth estimates
| Current qtr. | Next qtr. | Current year | Next year | |
|---|---|---|---|---|
| CVS.SN | -- | -- | -- | -- |
| S&P 500 | 10.39% | 9.41% | 13.53% | 14.03% |
Upgrades & downgrades
| Maintains | Evercore ISI Group: Outperform to Outperform | 1/27/2025 |
| Maintains | Truist Securities: Buy to Buy | 1/6/2025 |
| Upgrade | Deutsche Bank: Hold to Buy | 12/3/2024 |
| Maintains | TD Cowen: Buy to Buy | 11/25/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/25/2024 |
| Reiterates | Truist Securities: Buy to Buy | 11/20/2024 |